DuPont focusing on "nutraceuticals" category to help boost life sciences business.
This article was originally published in The Tan Sheet
Executive Summary
DUPONT ENTRY INTO "NUTRACEUTICALS" CATEGORY is part of a "three-fold" strategy the company is taking to spur growth in its life sciences division, DuPont Exec VP Kurt Landgraf told securities analysts during a teleconference May 11. In addition to boosting its pharmaceuticals and agriculture businesses, DuPont plans to focus on its nutraceuticals enterprise as the company pushes to generate higher life sciences sales and earnings.